Baclofen Api
₹17,000.00
Applications
Baclofen is used to manage severe muscle spasms of cerebral or spinal cord origins, including multiple sclerosis and traumatic brain injury.
Description
Baclofen is dedicated for adults and children in the relief of spasticity of voluntary muscle arising from conditions such as cerebral palsy, cerebrovascular accidents, traumatic head injury and meningitis.
Preparation
Methods for preparing sterilized baclofen solutions include adjusting the pH to below a desired pH, and steam sterilizing the solution with adjusted pH, which results in the solution having the desired pH. Such solutions may also have low concentrations of 4-CPP.
Chemical Properties
Baclofen API is a white to off-white crystalline powder with low solubility in water, recognized for its muscle relaxant properties, often used to treat muscle spasticity.
Definition
Baclofen API (Active Pharmaceutical Ingredient) is a compound used for its muscle relaxant properties, primarily prescribed to alleviate muscle spasticity.
Description
Product Name | Baclofen Api |
Usage/Application | Pharma |
Molar Mass | 213.661 g/mol |
Country of Origin | Made in India |
Formula | C10H12ClNO2 |
CAS ID | 1134-47-0 |
Boiling Point | 364.3 DegreeC |
Composition | BACLOFEN |
Prescription/Non prescription | Prescription |
Form | POWDER |
Grade | IP / BP / USP |
Therapeutic Category | Muscle Relaxant |
Packaging Size | As Per Requirement |
Our Export Location as a Baclofen Api Manufacturer, Supplier, Exporter, Stockist from India.
Afghanistan
Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Austrian Empire Azerbaijan Baden Bahamas Bahrain Bangladesh Barbados Bavaria Belarus Belgium Belize Benin (Dahomey) Bolivia Liberia Libya Liechtenstein Lithuania Luxembourg Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mecklenburg-Schwerin Mecklenburg-Strelitz Mexico Micronesia Moldova Monaco Mongolia Montenegro |
Bosnia and Herzegovina
Botswana Brazil Brunei Brunswick and Lüneburg Bulgaria Burkina Faso Burma Burundi Cabo Verde Cambodia Cameroon Canada Cayman Islands Central African Republic Central American Federation Chad Chile China Colombia Comoros Congo Free State Costa Rica Morocco Mozambique Namibia Nassau Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria North German Confederation North German Union North Macedonia Norway Oldenburg Oman Orange Free State Pakistan Palau Panama Papal States |
Cote d’Ivoire Croatia Cuba Cyprus Czechia Czechoslovakia Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Duchy of Parma East Germany Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Eswatini Ethiopia Federal Government of Germany Fiji Papua New Guinea Paraguay Peru Philippines Piedmont-Sardinia Poland Portugal Qatar Republic of Genoa* Republic of Korea (South Korea) Republic of the Congo Romania Russia Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia |
Schaumburg-Lippe* Finland France Gabon Gambia Georgia Germany Ghana Grand Duchy of Tuscany Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Hanover Hanseatic Republics Hawaii Hesse Holy See Honduras Hungary Iceland Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Sudan Spain Sri Lanka Sudan Suriname Sweden Switzerland Syria Tajikistan Tanzania Texas Thailand |
India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kingdom of Serbia/Yugoslavia Kiribati Korea Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Lew Chew (Loochoo) Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Two Sicilies* Uganda Ukraine Union of Soviet Socialist Republics* United Arab Emirates United Kingdom Uruguay Uzbekistan Vanuatu Venezuela Vietnam Württemberg* Yemen Zambia Zimbabwe |
Reviews
There are no reviews yet.